Dale Vincent, APRN

NPI: 1205164936
Total Payments
$24,973
2024 Payments
$2,561
Companies
51
Transactions
235
Medicare Patients
342
Medicare Billing
$20,921

Payment Breakdown by Category

Other$13,271 (53.1%)
Food & Beverage$4,889 (19.6%)
Travel$4,834 (19.4%)
Consulting$1,745 (7.0%)
Education$234.95 (0.9%)

Payments by Nature

Nature of Payment Amount Transactions Share
Honoraria $11,821 11 47.3%
Food and Beverage $4,889 211 19.6%
Travel and Lodging $4,834 4 19.4%
Consulting Fee $1,745 3 7.0%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1,450 1 5.8%
Education $234.95 5 0.9%

Top Paying Companies

Company Total Records Latest Year
Karyopharm Therapeutics Inc. $17,273 25 $0 (2024)
TG Therapeutics, Inc. $3,068 6 $0 (2022)
Janssen Biotech, Inc. $463.97 18 $0 (2024)
Merck Sharp & Dohme LLC $332.57 18 $0 (2024)
Incyte Corporation $319.76 7 $0 (2024)
Gilead Sciences, Inc. $311.36 17 $0 (2024)
ABBVIE INC. $296.75 13 $0 (2024)
Daiichi Sankyo Inc. $284.19 9 $0 (2024)
Novartis Pharmaceuticals Corporation $232.88 10 $0 (2024)
E.R. Squibb & Sons, L.L.C. $221.09 9 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $2,561 129 Merck Sharp & Dohme LLC ($267.55)
2023 $1,869 73 Janssen Biotech, Inc. ($243.49)
2022 $8,972 12 Karyopharm Therapeutics Inc. ($5,986)
2021 $11,572 21 Karyopharm Therapeutics Inc. ($11,132)

All Payment Transactions

235 individual payment records from CMS Open Payments — Page 1 of 10

Date Company Product Nature Form Amount Type
12/19/2024 Genentech USA, Inc. Itovebi (Biological), Polivy, Tecentriq Hybreza Food and Beverage In-kind items and services $22.98 General
Category: BioOncology
12/18/2024 Karyopharm Therapeutics Inc. XPOVIO (Drug) Food and Beverage In-kind items and services $19.03 General
Category: Oncology
12/17/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $18.93 General
12/16/2024 Merck Sharp & Dohme LLC KEYTRUDA (Biological) Food and Beverage In-kind items and services $20.47 General
Category: ONCOLOGY
12/05/2024 PFIZER INC. INLYTA (Drug), PADCEV Food and Beverage In-kind items and services $23.24 General
Category: ONCOLOGY
12/02/2024 AstraZeneca Pharmaceuticals LP ENHERTU (Biological) Education In-kind items and services $25.95 General
Category: Oncology
12/02/2024 PUMA BIOTECHNOLOGY, INC. Food and Beverage In-kind items and services $20.00 General
11/26/2024 Daiichi Sankyo Inc. Enhertu (Drug) Food and Beverage In-kind items and services $21.00 General
Category: ONCOLOGY
11/23/2024 Novartis Pharmaceuticals Corporation PLUVICTO (Drug) Food and Beverage In-kind items and services $21.78 General
Category: Oncology
11/20/2024 Janssen Biotech, Inc. ERLEADA (Drug) Food and Beverage In-kind items and services $14.21 General
Category: Oncology
11/19/2024 Novartis Pharmaceuticals Corporation Fabhalta (Drug) Food and Beverage In-kind items and services $20.67 General
Category: Immunology
11/15/2024 Daiichi Sankyo Inc. Enhertu (Drug) Food and Beverage In-kind items and services $15.27 General
Category: ONCOLOGY
11/14/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $6.47 General
11/13/2024 Alexion Pharmaceuticals, Inc. ULTOMIRIS (Biological) Food and Beverage In-kind items and services $26.24 General
Category: Rare Disease
11/12/2024 Merck Sharp & Dohme LLC KEYTRUDA (Biological), WELIREG Food and Beverage In-kind items and services $7.46 General
Category: ONCOLOGY
11/09/2024 Blueprint Medicines Corporation AYVAKIT (Drug) Food and Beverage In-kind items and services $36.94 General
Category: Oncology / Rare Diseases
11/08/2024 ABBVIE INC. EPKINLY (Drug) Food and Beverage In-kind items and services $17.46 General
Category: ONCOLOGY
11/05/2024 Incyte Corporation JAKAFI (Drug) Food and Beverage Cash or cash equivalent $29.02 General
Category: Hematology/Oncology
10/31/2024 Celgene Corporation REBLOZYL (Biological) Food and Beverage Cash or cash equivalent $15.94 General
Category: Hematology
10/29/2024 AstraZeneca Pharmaceuticals LP LYNPARZA (Drug) Food and Beverage In-kind items and services $22.88 General
Category: Oncology
10/25/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $26.49 General
10/24/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $17.37 General
10/22/2024 Novartis Pharmaceuticals Corporation SCEMBLIX (Drug) Food and Beverage In-kind items and services $27.43 General
Category: Oncology
10/18/2024 Stemline Therapeutics Inc. ELZONRIS (Drug) Food and Beverage In-kind items and services $23.03 General
Category: Oncology
10/17/2024 Janssen Biotech, Inc. ERLEADA (Drug) Food and Beverage In-kind items and services $15.82 General
Category: Oncology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 3 150 204 $42,219 $10,573
2022 2 76 80 $16,376 $4,283
2021 2 44 50 $10,397 $2,893
2020 2 72 78 $15,282 $3,172
Total Patients
342
Total Services
412
Medicare Billing
$20,921
Procedure Codes
9

All Medicare Procedures & Services

9 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2023 64 83 $20,189 $4,918 24.4%
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2023 75 107 $18,404 $4,478 24.3%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 11 14 $3,626 $1,177 32.5%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2022 52 56 $12,824 $3,287 25.6%
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2022 24 24 $3,552 $996.28 28.0%
99214 Established patient outpatient visit, total time 30-39 minutes Facility 2021 31 37 $8,473 $2,361 27.9%
99213 Established patient outpatient visit, total time 20-29 minutes Facility 2021 13 13 $1,924 $532.56 27.7%
99214 Established patient office or other outpatient, visit typically 25 minutes Facility 2020 40 46 $10,536 $2,314 22.0%
99213 Established patient office or other outpatient visit, typically 15 minutes Facility 2020 32 32 $4,746 $858.11 18.1%

About Dale Vincent, APRN

Dale Vincent, APRN is a Family healthcare provider based in Bardstown, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/18/2009. The National Provider Identifier (NPI) number assigned to this provider is 1205164936.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dale Vincent, APRN has received a total of $24,973 in payments from pharmaceutical and medical device companies, with $2,561 received in 2024. These payments were reported across 235 transactions from 51 companies. The most common payment nature is "Honoraria" ($11,821).

As a Medicare-enrolled provider, Vincent has provided services to 342 Medicare beneficiaries, totaling 412 services with total Medicare billing of $20,921. Data is available for 4 years (2020–2023), covering 9 distinct procedure/service records.

Practice Information

  • Specialty Family
  • Other Specialties Family
  • Location Bardstown, KY
  • Active Since 11/18/2009
  • Last Updated 01/11/2023
  • Taxonomy Code 363LF0000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1205164936

Products in Payments

  • XPOVIO (Drug) $17,273
  • UKONIQ (Drug) $3,068
  • KEYTRUDA (Biological) $332.57
  • DARZALEX (Biological) $201.55
  • VENCLEXTA (Drug) $190.62
  • JAKAFI (Drug) $181.10
  • Enhertu (Drug) $175.69
  • LIBTAYO (Biological) $149.88
  • BRUKINSA (Drug) $130.19
  • ELIQUIS (Drug) $129.41
  • ERLEADA (Drug) $122.90
  • ENHERTU (Drug) $108.50
  • TUKYSA (Drug) $105.88
  • IMBRUVICA (Drug) $101.82
  • IBRANCE (Drug) $93.51
  • EPKINLY (Drug) $91.67
  • BAVENCIO (Drug) $91.16
  • ADCETRIS (Biological) $90.26
  • LUTATHERA (Drug) $82.56
  • ENHERTU (Biological) $70.85

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Doctors in Bardstown